Pituitary adenylate cyclase-activating peptide (PACAP) is present and
synthesized in the testis in large amounts. Messenger RNA encoding the
peptide is expressed in a stage specific manner in the developing ger
m cells. PACAP regulates a variety of physiological actions, among the
m, paracrine modulation of spermatogenesis. The PACAP peptides are pot
ential ligands of at least three receptor types, the type I PACAP rece
ptor, VIP1 and VIP2 receptors. Although PACAP27 binding sites have fou
nd in the testis, the receptor at which it acts has not been identifie
d. We used in situ hybridization with riboprobes to identify the PACAP
binding receptor present in the testis. Neither type I PACAP receptor
, nor VIP1 receptor mRNA was present within the germ cells. Using the
VIP2 receptor probe there was strong labelling within some cross secti
ons of the seminiferous tubuli, while others were not labelled. The in
situ results were also confirmed using reverse-transcription PCR (RT-
PCR). Our data suggest that PACAP mediates its possible paracrine effe
ct in the testis through the VIP2 receptor.